The Vall d'Hebron University Hospital is a public and university affiliated hospital founded in 1955. It belongs to the Catalan Health Institute and is the hospital complex with the highest volume of interventions in Catalonia, Spain.

There are 1,146 beds in Hospital General Vall D'Hebron.

During the past decade, Hospital General Vall D'Hebron conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital General Vall D'Hebron" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 10 trials, followed by "Pfizer" with 3 trials sponsored, "Actelion" with 1 trials sponsored, "Clinical Trial Agency of HIV Study Group" with 1 trials sponsored and "Instituto Grifols, S.A." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital General Vall D'Hebron" #1 collaborator was "Amgen" with 1 trials as a collaborator, "Borstkanker Onderzoek Groep" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "British Medical Research Council" with 1 trials as a collaborator and "Cancer Trials Ireland" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Hospital General Vall D'Hebron" are "Colorectal Cancer Metastatic" (2 trials), "Sarcoma" (2 trials), "Acromegaly" (1 trials), "Advanced Cancer" (1 trials) and "Advanced Colorectal Cancer" (1 trials). Many other conditions were trialed in "Hospital General Vall D'Hebron" in a lesser frequency.

Most popular intervention types in "Hospital General Vall D'Hebron" are "Drug" (13 trials), "Procedure" (3 trials), "Biological" (2 trials), "Genetic" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Tumour markers testing" (2 trials), "placebo" (2 trials), "3-dimensional conformal radiation therapy" (1 trials) and "5-fluorouracil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital General Vall D'Hebron" are 16 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital General Vall D'Hebron". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Hospital General Vall D'Hebron, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital General Vall D'Hebron, 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".